SGLT2 inhibitor

jardiance chronic kidney disease fda approval, lilly boehringer jardiance kidney disease, jardiance vs farxiga kidney disease, jardiance kidney disease trial results, jardiance kidney disease indication, jardiance kidney disease benefits, jardiance kidney disease market
Latest News Approvals Pharma

Jardiance gets FDA green light for chronic kidney disease, challenging AstraZeneca’s rival drug

Anika Sharma

Shortly after securing European approval for the treatment of chronic kidney disease (CKD), Eli Lilly and Boehringer Ingelheim have achieved ...

How Jardiance Lifts Boehringer Ingelheim’s Revenue as US Decision Looms
Latest News Pharma

Boehringer Ingelheim Soars with Jardiance Growth as US Kidney Disease Approval Looms

SG Tylor

Source – Boehringer Ingelheim Boehringer Ingelheim is gearing up for the launch of Jardiance, a diabetes and heart failure drug, ...

Pharmtales - your go-to source for comprehensive coverage of the pharmaceutical industry.

pharmtales
Latest Pharma News & Insights

© 2024 pharmtales.com | All rights reserved.

PRIVACY POLICY terms of service Contact us